Asenapine, a novel psychopharmacologic agent with efficacy in positive and negative symptoms during acute episodes of schizophrenia: A randomized, placebo-and risperidone-controlled trial

被引：0
|
作者：
Potkin, SG [1 ]
Cohen, M [1 ]
Baker, RA [1 ]
Jina, AS [1 ]
Alphs, L [1 ]
Nettler, S [1 ]
Panagides, J [1 ]
机构：
[1] Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine Brain Imaging Ctr, Irvine, CA 92697 USA
来源：
SCHIZOPHRENIA RESEARCH | 2006年 / 81卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：62 / 62
页数：1
相关论文
共 50 条
  • [1] Asenapine, a novel psychotherapeutic agent with efficacy in positive and negative symptoms during acute episodes of schizophrenia: A randomized, placebo- and risperidone-controlled trial
    Potkin, SG
    Cohen, M
    Baker, RA
    Jina, AS
    Nettler, S
    Alphs, L
    Panagides, J
    [J]. NEUROPSYCHOPHARMACOLOGY, 2005, 30 : S112 - S113
  • [2] Asenapine cognitive function effects in acute schizophrenia: A placebo-and risperidone-controlled trial
    Potkin, S.
    Fleming, K.
    Binneman, B.
    Keller, S.
    [J]. SCHIZOPHRENIA BULLETIN, 2007, 33 (02) : 454 - 454
  • [3] Asenapine efficacy in acute schizophrenia: A randomized, placebo- and risperidone-controlled trial
    Potkin, S. G.
    Cohen, M.
    Panagides, J.
    Jina, A. S.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S275 - S275
  • [4] Efficacy and tolerability of asenapine in acute schizophrenia: A placebo- and risperidone-controlled trial
    Potkin, Steven G.
    Cohen, Miriam
    Panagides, John
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (10) : 1492 - 1500
  • [5] Asenapine efficacy, safety, and tolerability in the treatment of acute schizophrenia: A randomized, placebo- and risperidone-controlled trial
    Potkin, SG
    Cohen, M
    Panagides, J
    Jina, AS
    [J]. BIOLOGICAL PSYCHIATRY, 2006, 59 (08) : 154S - 154S
  • [6] Asenapine safety and tolerability in acute schizophrenia: A placebo- and risperidone-controlled trial
    Potkin, S. G.
    Cohen, M.
    Panagides, J.
    Jina, A. S.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S276 - S276
  • [7] Asenapine safety and tolerability in acute schizophrenia: a placebo- and risperidone-controlled trial
    Potkin, S. G.
    Cohen, M.
    Panagides, J.
    Jina, A.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S401 - S402
  • [8] Asenapine cognitive function effects in acute schizophrenia: A placebo- and risperidone-controlled trial
    Potkin, Steven G.
    Fleming, Kirsten
    Binneman, Brendon
    Keller, David S.
    Alphs, Larry
    Panagides, John
    [J]. NEUROPSYCHOPHARMACOLOGY, 2006, 31 : S251 - S251
  • [9] Asenapine has cognitive function effects in acute schizophrenia: A placebo-controlled and risperidone-controlled trial
    Fleming, Kirsten
    Potkin, Steven G.
    Binneman, Brendon
    Keller, David S.
    Alphs, Larry
    Panagides, John
    [J]. BIOLOGICAL PSYCHIATRY, 2007, 61 (08) : 241S - 241S
  • [10] A placebo-controlled trial of bupropion for improving the positive and negative symptoms of schizophrenia
    Rezaee, Omid
    Masafi, Saeede M.
    Mohamadreza
    Farshad, Akbarpour
    [J]. INTERNATIONAL JOURNAL OF COLLABORATIVE RESEARCH ON INTERNAL MEDICINE & PUBLIC HEALTH, 2012, 4 (06) : 1223 - 1230
12345